ArticleACR open rheumatology2022

Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study.

Lubna Abuqayyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.